Phase 2 trial of intensity-modulated radiation therapy +/- concurrent doxorubicin for patients with locally advanced or recurrent non-anaplastic thyroid cancer Meeting Abstract
| Authors: | Romesser, P. B.; Sherman, E.; Shaha, A.; Sabra, M.; Sabol, C.; Brinkman, T.; Spielsinger, D.; Tuttle, R. M.; Fagin, J.; Wong, R. J.; Lee, N. |
| Abstract Title: | Phase 2 trial of intensity-modulated radiation therapy +/- concurrent doxorubicin for patients with locally advanced or recurrent non-anaplastic thyroid cancer |
| Meeting Title: | 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 99 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2017 Sep 24-27 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-10-01 |
| Start Page: | E368 |
| Language: | English |
| ACCESSION: | WOS:000411559103044 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2017.06.1481 |
| Notes: | Meeting Abstract: 2873 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
